Nuvation Bio Inc.
Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors

Last updated:

Abstract:

Novel bromodomain and extraterminal domain (BET) inhibitors contanining substituted 2-pyridones and therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.

Status:
Grant
Type:

Utility

Filling date:

30 Oct 2019

Issue date:

7 Dec 2021